Information Library

Targeted communications

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • Re-energizing a Brand

    September 1, 2010
    Learn how Quintiles revamped the consumer marketing plan for an oral health product, boosting brand awareness by 90% and expanding the overall market size.

  • NHS Motivating Patients

    May 7, 2010
    In 2008, the NHS announced plans to offer free health checks for heart disease, stroke, diabetes and kidney disease. Learn why Quintiles was the right ally for the NHS to successfully launch this cardio risk assessment program.

  • Commercial – identify, promote and prove treatment value

    April 1, 2010
    Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success.

  • IMC wins PMEA award

    December 10, 2009
    Medical communications group wins PMEA award for best European Marketing Campaign with Pfizer

  • QUINTILES AND ALLERGAN ANNOUNCE CO-PROMOTION AGREEMENT

    September 25, 2009 – Quintiles Transnational Corp. and Allergan, Inc. today announced an agreement under which Quintiles will co-promote Allergan's SANCTURA XR®.

  • Utility of Adiponectin as a Biomarker Predictive of Glycemic Efficacy

    June 29, 2009
    The project pooled blinded data from existing completed clinical trials contributed by Eli Lilly and Company, GlaxoSmithKline, Hoffmann-LaRoche, Inc, and Merck Research Laboratories into a single database hosted by Quintiles Transnational Corporation.

  • Medicare Part D’s Effect On Prescribing Volume

    June 25, 2009
    Poster presented during the ISPOR 14th Annual International Meeting 2009 (International Society for Pharmacoeconomics and Outcomes Research) titled “Medicare Part D’s Effect On Prescribing Volume: Average Monthly Utilization of Selected High Use Drugs In The Six Protected Classes, By Different Specialties.”

  • Diabetes Proactive Proposal

    June 24, 2009
    New FDA Guidances On Antidiabetic Therapies Change the Landscape of Drug Development. How Quintiles Can Help You Navigate the Guidances and Successfully Develop Pipeline Drug Candidates.

  • Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.

    June 24, 2009
    Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009 (International Society for Pharmacoeconomics and Outcomes Research) on “The Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.”

  • Organizing Events, Advisory Boards and Meetings

    June 5, 2009
    In the past 5 years, medical communications has delivered over 250 meetings to 13,500 delegates.

Page 1 of 2 (19 results)

Subscribe to Email Based on Your Interests

Set preferences